The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Engineering bacteria as interactive cancer therapies
Open accessAbstract
With increasing evidence that microbes colonize tumors, synthetic biology tools are being leveraged to repurpose bacteria as tumor-specific delivery systems. These engineered systems can modulate the tumor microenvironment using a combination of their inherent immunogenicity and local payload production. Here, we review genetic circuits that enhance spatial and temporal control of therapeutic bacteria to improve their safety and efficacy. We describe the engineering of interactions among bacteria, tumor cells, and immune cells, and the progression from bacteria as single agents toward their rational combination with other modalities. Together, these efforts are building toward an emerging concept of engineering interactions between programmable medicines using synthetic biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., et al. (2020) · Science · doi:10.1126/science.aay9189 · Cited by 2,464
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Tanoue, T., Morita, S., Plichta, D. R., Skelly, A. N., Suda, W., Sugiura, Y., Narushima, S., Vlamakis, H., Motoo, I., Sugita, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0878-z · Cited by 1,145
Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
Felfoul, O., Mohammadi, M., Taherkhani, S., de Lanauze, D., Zhong Xu, Y., Loghin, D., Essa, S., Jancik, S., Houle, D., Lafleur, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.137 · Cited by 1,106
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905
In vitro and ex vivo strategies for intracellular delivery
Stewart, M. P., Sharei, A., Ding, X., Sahay, G., Langer, R., & Jensen, K. F. (2016) · Nature · doi:10.1038/nature19764 · Cited by 885
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Synchronized cycles of bacterial lysis for in vivo delivery
Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., et al. (2016) · Nature · doi:10.1038/nature18930 · Cited by 784
Self-citationThe toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas.
McCarthy, E. F. (2006) · Europe PMC (PubMed Central) · Cited by 747
Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Chowdhury, S., Castro, S., Coker, C., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2019) · Nature Medicine · doi:10.1038/s41591-019-0498-z · Cited by 724
Self-citationEngineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Gurbatri, C. R., Lia, I., Vincent, R., Coker, C., Castro, S., Treuting, P. M., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0876 · Cited by 647
Self-citationMetabolic modulation of tumours with engineered bacteria for immunotherapy
Canale, F. P., Basso, C., Antonini, G., Perotti, M., Li, N., Sokolovska, A., Neumann, J., James, M. J., Geiger, S., Jin, W., et al. (2021) · Nature · doi:10.1038/s41586-021-04003-2 · Cited by 619
Secretory and extracellular production of recombinant proteins using Escherichia coli
Choi, J. H., & Lee, S. Y. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1559-9 · Cited by 614
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614
Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9537 · Cited by 588
Environmentally Controlled Invasion of Cancer Cells by Engineered Bacteria
Anderson, J. C., Clarke, E. J., Arkin, A. P., & Voigt, C. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.076 · Cited by 572
Bacteria-cancer interactions: bacteria-based cancer therapy
Duong, M. T.-Q., Qin, Y., You, S.-H., & Min, J.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0297-0 · Cited by 519
Low, K. B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., et al. (1999) · Nature Biotechnology · doi:10.1038/5205 · Cited by 476
Programmable probiotics for detection of cancer in urine
Danino, T., Prindle, A., Kwong, G. A., Skalak, M., Li, H., Allen, K., Hasty, J., & Bhatia, S. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3519 · Cited by 467
Self-citationImmunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Leventhal, D. S., Sokolovska, A., Li, N., Plescia, C., Kolodziej, S. A., Gallant, C. W., Christmas, R., Gao, J.-R., James, M. J., Abin-Fuentes, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16602-0 · Cited by 458
Identification of bacteria-derived HLA-bound peptides in melanoma
Kalaora, S., Nagler, A., Nejman, D., Alon, M., Barbolin, C., Barnea, E., Ketelaars, S. L. C., Cheng, K., Vervier, K., Shental, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03368-8 · Cited by 457
Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts
Bourdeau, R. W., Lee-Gosselin, A., Lakshmanan, A., Farhadi, A., Kumar, S. R., Nety, S. P., & Shapiro, M. G. (2018) · Nature · doi:10.1038/nature25021 · Cited by 396
Designing microbial consortia with defined social interactions
Kong, W., Meldgin, D. R., Collins, J. J., & Lu, T. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0091-7 · Cited by 327
Zhao, M., Yang, M., Ma, H., Li, X., Tan, X., Li, S., Yang, Z., & Hoffman, R. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0716 · Cited by 305
Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention
Ho, C. L., Tan, H. Q., Chua, K. J., Kang, A., Lim, K. H., Ling, K. L., Yew, W. S., Lee, Y. S., Thiery, J. P., & Chang, M. W. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0181-y · Cited by 303
Akolpoglu, M. B., Alapan, Y., Dogan, N. O., Baltaci, S. F., Yasa, O., Aybar Tural, G., & Sitti, M. (2022) · Science Advances · doi:10.1126/sciadv.abo6163 · Cited by 293
Ultrasound-controllable engineered bacteria for cancer immunotherapy
Abedi, M. H., Yao, M. S., Mittelstein, D. R., Bar-Zion, A., Swift, M. B., Lee-Gosselin, A., Barturen-Larrea, P., Buss, M. T., & Shapiro, M. G. (2022) · Nature Communications · doi:10.1038/s41467-022-29065-2 · Cited by 260
A programmable encapsulation system improves delivery of therapeutic bacteria in mice
Harimoto, T., Hahn, J., Chen, Y.-Y., Im, J., Zhang, J., Hou, N., Li, F., Coker, C., Gray, K., Harr, N., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01244-y · Cited by 260
Self-citationFunctional gene transfer from intracellular bacteria to mammalian cells
Grillot-Courvalin, C., Goussard, S., Huetz, F., Ojcius, D. M., & Courvalin, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-862 · Cited by 230
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch, J. P., Goers, L., & Lesser, C. F. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.002 · Cited by 230
Wang, W., Xu, H., Ye, Q., Tao, F., Wheeldon, I., Yuan, A., Hu, Y., & Wu, J. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00834-6 · Cited by 206
Chen, Y., Du, M., Yuan, Z., Chen, Z., & Yan, F. (2022) · Nature Communications · doi:10.1038/s41467-022-31932-x · Cited by 189
Magnetic torque–driven living microrobots for increased tumor infiltration
Gwisai, T., Mirkhani, N., Christiansen, M. G., Nguyen, T. T., Ling, V., & Schuerle, S. (2022) · Science Robotics · doi:10.1126/scirobotics.abo0665 · Cited by 189
Yu, B., Yang, M., Shi, L., Yao, Y., Jiang, Q., Li, X., Tang, L.-H., Zheng, B.-J., Yuen, K.-Y., Smith, D. K., et al. (2012) · Scientific Reports · doi:10.1038/srep00436 · Cited by 181
Park, S.-H., Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Kim, D.-Y., Szardenings, M., Min, J. H., Hong, Y., Choy, H. E., & Min, J.-J. (2016) · Theranostics · doi:10.7150/thno.16135 · Cited by 176
Automated design of synthetic microbial communities
Karkaria, B. D., Fedorec, A. J. H., & Barnes, C. P. (2021) · Nature Communications · doi:10.1038/s41467-020-20756-2 · Cited by 175
Raman, V., Van Dessel, N., Hall, C. L., Wetherby, V. E., Whitney, S. A., Kolewe, E. L., Bloom, S. M. K., Sharma, A., Hardy, J. A., Bollen, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26367-9 · Cited by 171
Acoustically triggered mechanotherapy using genetically encoded gas vesicles
Bar-Zion, A., Nourmahnad, A., Mittelstein, D. R., Shivaei, S., Yoo, S., Buss, M. T., Hurt, R. C., Malounda, D., Abedi, M. H., Lee-Gosselin, A., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00971-8 · Cited by 166
Enhancing the tropism of bacteria via genetically programmed biosensors
Chien, T., Harimoto, T., Kepecs, B., Gray, K., Coker, C., Hou, N., Pu, K., Azad, T., Nolasco, A., Pavlicova, M., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00772-3 · Cited by 164
Self-citationEngineering the Salmonella type III secretion system to export spider silk monomers
Widmaier, D. M., Tullman‐Ercek, D., Mirsky, E. A., Hill, R. M., Govindarajan, S., Minshull, J., & Voigt, C. A. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.62 · Cited by 161
Rock-paper-scissors: Engineered population dynamics increase genetic stability
Liao, M. J., Din, M. O., Tsimring, L., & Hasty, J. (2019) · Science · doi:10.1126/science.aaw0542 · Cited by 160
Tweak to Treat: Reprograming Bacteria for Cancer Treatment
Sieow, B. F.-L., Wun, K. S., Yong, W. P., Hwang, I. Y., & Chang, M. W. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.11.004 · Cited by 158
Quorum-sensing Salmonella selectively trigger protein expression within tumors
Swofford, C. A., Van Dessel, N., & Forbes, N. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414558112 · Cited by 145
Theranostic cells: emerging clinical applications of synthetic biology
McNerney, M. P., Doiron, K. E., Ng, T. L., Chang, T. Z., & Silver, P. A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00383-3 · Cited by 141
Development of a Listeria monocytogenes based vaccine against prostate cancer
Shahabi, V., Reyes-Reyes, M., Wallecha, A., Rivera, S., Paterson, Y. Y. W., & Maciag, P. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0463-z · Cited by 98
Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice
Selvanesan, B. C., Chandra, D., Quispe‐Tintaya, W., Jahangir, A., Patel, A. S., Meena, K., da Silva, R. A. A., Friedman, M., Gabor, L. R., Khouri, O. R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abc1600 · Cited by 95
Engineering Salmonella as intracellular factory for effective killing of tumour cells
Camacho, E. M., Mesa‐Pereira, B., Medina, C., Flores, A., & Santero, E. (2016) · Scientific Reports · doi:10.1038/srep30591 · Cited by 81
Wild-type intracellular bacteria deliver DNA into mammalian cells
Grillot‐Courvalin, C., Goussard, S., & Courvalin, P. M. (2002) · Cellular Microbiology · doi:10.1046/j.1462-5822.2002.00184.x · Cited by 72
Bacterial-Mediated Knockdown of Tumor Resistance to an Oncolytic Virus Enhances Therapy
Cronin, M. A., Boeuf, F. L., Murphy, C., Roy, D. G., Falls, T. J., Bell, J. C., & Tangney, M. (2014) · Molecular Therapy · doi:10.1038/mt.2014.23 · Cited by 49
Engineered Attenuated Salmonella typhimurium Expressing Neoantigen Has Anticancer Effects
Hyun, J., Jun, S., Lim, H., Cho, H., You, S.-H., Ha, S., Min, J.-J., & Bang, D. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00097 · Cited by 42
Guo, F., Das, J. K., Kobayashi, K. S., Qin, Q., Ficht, T. A., Alaniz, R. C., Song, J. J., & de Figueiredo, P. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003760 · Cited by 38
Tumor-targeting amino acid auxotrophic Salmonella typhimurium
Hoffman, R. M. (2009) · Amino Acids · doi:10.1007/s00726-009-0261-8 · Cited by 31
Salmonella-based platform for efficient delivery of functional binding proteins to the cytosol
Chabloz, A., Schaefer, J. V., Kozieradzki, I., Cronin, S. J. F., Strebinger, D., Macaluso, F., Wald, J., Rabbitts, T. H., Plückthun, A., Marlovits, T. C., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1072-4 · Cited by 27
Scalable recombinase-based gene expression cascades
Kim, T., Weinberg, B. H., Wong, W. W., & Lu, T. K. (2021) · Nature Communications · doi:10.1038/s41467-021-22978-4 · Cited by 23
Recent Progress in the Molecular Imaging of Tumor-Treating Bacteria
Kang, S., & Min, J. (2021) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-021-00689-4 · Cited by 13
Probiotic-guided CAR-T cells for universal solid tumor targetingPreprint
Vincent, R. L., Gurbatri, C. R., Redenti, A., Coker, C., Arpaia, N., & Danino, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.10.463366 · Cited by 13
Self-citationMagnetic torque-driven living microrobots for enhanced tumor infiltrationPreprint
Gwisai, T., Mirkhani, N., Christiansen, M. G., Nguyen, T. T., Ling, V., & Schuerle, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.03.473989 · Cited by 6
Engineered bacteria detect tumor DNAPreprint
Cooper, R. M., Wright, J. A., Ng, J. Q., Goyne, J. M., Suzuki, N., Lee, Y. K., Ichinose, M., Radford, G., Ryan, F. J., Kumar, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.10.459858 · Cited by 4
Engineered bacteria recruit and orchestrate anti-tumor immunityPreprint
Savage, T. M., Vincent, R. L., Rae, S. S., Huang, L. H., Ahn, A., Pu, K., Li, F., Coker, C., Danino, T., & Arpaia, N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.16.496462 · Cited by 3
Self-citationEngineered E. coli for the targeted deposition of therapeutic payloads to sites of diseasePreprint
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Glickman, J. N., Leong, J. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1233122/v1 · Cited by 2
Cited by
Lim, W. A. (2022) · Science · doi:10.1126/science.add9665 · Cited by 101
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Wang, Z., Sun, W., Hua, R., Wang, Y., Li, Y., & Zhang, H. (2024) · International Journal of Oral Science · doi:10.1038/s41368-024-00282-3 · Cited by 97
Melanoma and microbiota: Current understanding and future directions
Routy, B., Jackson, T., Mählmann, L., Baumgartner, C. K., Blaser, M., Byrd, A., Corvaia, N., Couts, K., Davar, D., Derosa, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.003 · Cited by 89
Zhu, L., Song, G., Zhang, W., Wu, Y., Chen, Y., Song, J., Wang, D., Li, G., Tang, B. Z., & Li, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-57533-y · Cited by 63
Wang, J., Liang, S., Chen, S., Ma, T., Chen, M., Niu, C., Leng, Y., & Wang, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02619-w · Cited by 53
Metadata
- Authors
- Gurbatri, C. R., Arpaia, N., & Danino, T.
- Venue
- Science
- Published
- 2022-11-25
- Volume
- 378
- Issue
- 6622
- Pages
- 858-864
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4310251760
- Cited by
- 447
- References
- 60
- FWCI
- 32.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.